RMC No. 103-2021: Updated List of VAT-Exempt Medicines and COVID-19 Drugs for Immediate Compliance

RMC No. 103-2021 publishes updated VAT-exempt lists of medicines for hypertension, cancer, kidney diseases, and COVID-19 drugs, requiring immediate compliance for affected businesses. Businesses and taxpayers dealing with pharmaceutical products and COVID-19 treatments must immediately review the updated VAT-exempt lists published by the FDA and DOH. This update, under RMC No. 103-2021, supplements prior guidelines […]